Tara Bancroft
Stock Analyst at TD Cowen
(2.74)
# 1,847
Out of 5,182 analysts
11
Total ratings
66.67%
Success rate
20.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintains: Buy | $90 → $100 | $102.62 | -2.55% | 2 | Feb 26, 2026 | |
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $21.53 | +57.92% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $9.59 | +108.55% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $82.82 | -3.40% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $36.92 | +35.43% | 1 | Oct 29, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.50 | +566.67% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $4.85 | - | 1 | Aug 31, 2022 |
Protagonist Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $90 → $100
Current: $102.62
Upside: -2.55%
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $21.53
Upside: +57.92%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $9.59
Upside: +108.55%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $82.82
Upside: -3.40%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $36.92
Upside: +35.43%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $4.85
Upside: -